Clinical research on the signaling pathways leading to atherosclerosis has suggested that components of NETosis evoke NLRP3 inflammasome activation, which releases the proinflammatory cytokines IL-1β and IL-18. This evidence concerns the gene IL18 and atherosclerosis.